Benzinga | Jul 29, 2021 06:43AM EDT

Evelo Biosciences Q2 EPS $(0.59) Misses $(0.54) Estimate

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.54) by 9.26 percent. This is a 6.35 percent increase over losses of $(0.63) per share from the same period last year.